---
templateKey: publications-page
title: Publications
subtitle: >-
  Nature Scientific Reports, Nature Communications, Clinical Cancer Research,
  Tumor Biology, Cell Signal...
headerImage: /img/dna-1811955_1280.jpg
---
# 2018

* Moamer A, Binothman N, Hachim I, Lebrun JJ, Ali S. (2018)

**_Critical Role for Kinesin 1 Heavy Chain KIF5B in TNBC Aggressive Phenotype Independent of its Partner Protein Kinesin-1 Light Chain KLC1_**. EMBO J Submitted (2018).

* Hachim I, López-Ozuna VM, Hachim M, Lebrun JJ, Ali S. (2018) 

_**Prolactin Hormone Exerts Anti-Tumorigenic Effects in HER-2 Overexpressing Breast Cancer Cells through Regulation of Tumor Initiation and Stemness**._ Nature Scientific Reports (submitted).

* Fils-Aime N, Poulet S, Neel JC, Dai, M, Hachim, I, Ali S, Lebrun JJ. (2018) 

**_Blocking microRNA-30 in triple negative breast Cancer can restore pro-apoptotic programs and block tumor development in vivo_**. Nature Communications (submitted).

* Tian J, Al Raffa F, Dai M, Khandag B, Bakdounes K, Jean-Claude B, Ali S, Lebrun JJ. (2018).

_**Dasatinib targeting of breast cancer stem cells sensitize triple negative breast cancer cells to chemotherapy**._ Clin Cancer Res (submitted).

* Hachim MY, Hachim IY, Dai M, Ali S, Lebrun JJ. (2018) 

**_Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression_**. Tumor Biology Jan;40(1):1010428317748254. 

doi:10.1177/1010428317748254. PMID: 29320969

* Tian J, AlOdaini A, Wang Y, Dai M, Ali S, Lebrun JJ. (2018). 

**_KiSS1 gene as a novel mediator of TGFβ pro-invasive effects in triple negative breast cancer_.** Cell Signal. 2018 Jan;42:1-10. 

doi: 10.1016/j.cellsig.2017.10.002. Epub 2017 Oct 6. PMID:28988968

# 2017

* Hachim IY, Villatoro M, Canaff L, Hachim M, Boudreault J, Haiub H, Ali S, Lebrun JJ. (2017).

**_Transforming Growth Factorbeta Regulation Of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration._** Nature Scientific Reports. 2017 Nov 3;7(1):14976. 

doi: 10.1038/s41598-017-14549-9. PMID: 29101386

* Binothman N, Hachim IY, Lebrun JJ, Ali S. (2017). 

**_CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer._ **EBioMedicine 2017 Jul;21:65-78. 

doi: 10.1016/j.ebiom.2017.06.023. Epub 2017 Jun 24. PMID:28673861

* Tian J, Hachim MY, Hachim IY, Dai M, Lo C, Al Raffa F, Ali S, Lebrun JJ. (2017).

**_Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer._** Nature Scientific Reports. Scientific Reports 7, Article number: 40258 (2017).

doi:10.1038/srep40258

* Lopez-Ozuna VM, Hachim YI, Hachim YM, Lebrun JJ., Ali, S. (2016) 

**_Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy_**. Nature Scientific Reports. 2016 Aug 2; 6:30934. 

doi: 10.1038/srep30934

* Dai M, Zhang C, Ali A, Hong X, Lebrun JJ. (2016) 

**_Characterization of CDK4 as a cancer stem cell regulator, prognostic marker and therapeutic target for triple-negative breast cancer_**. Nature Scientific Reports. 2016 Oct 19; 6:35383. 

doi:10.1038/srep35383

* Guo J, Fung BCM, Kuppen PJK, Tollenaar RAEM, Mesker WE, and Lebrun JJ. (2017) 

_**Revealing Determinant Factors for Early Breast Cancer Recurrence by Decision Tree**_. Information Systems Frontiers (ISF), 13 pages, in press. Springer.
